44 employees
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
2021
$55M
from 5 investors over 5 rounds
Replay raised $55M on July 25, 2022
Investors: SALT Ventures Indonesia, OMX Ventures, KKR & Co. Inc. and ARTIS Ventures
Replay raised undisclosed on August 1, 2020
Investors: ARTIS Ventures